3 ms·
> Although multiple antiviral and host target activities have been reported for ivermectin in SARS-CoV-2 and COVID-19, it is still unclear if any of these activ
by gundmc 5y ago
> Although multiple antiviral and host target activities have been reported for ivermectin in SARS-CoV-2 and COVID-19, it is still unclear if any of these activities will play a role in the prevention and treatment of the disease. The controlled clinical trials that are underway will reveal if these activities will translate into clinical efficacy.
- wsc981 5y agoClinical trials for ivermectin have been stopped at least 2 times now due to weird reasons. First one in Australia was stopped due to apparently being too few COVID infected people. In the last couple of weeks the Oxford trial was stopped because apparently there was a supply problem with ivermectin, according to Merck.